SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, announced today that China's National Medical ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 15, 2025 (HealthDay News) — Breathing problems are common among people with ...

After the loss of his mother to ALS, a Kansas City man gave two Chiefs fans who are ALS patients the tour of a lifetime.

Four people living with severe paralysis, caused by conditions including amyotrophic lateral sclerosis and brainstem stroke, took part in the trial. One participant could only respond ...

In a recent study, scientists successfully decoded not only the words people tried to say but the words they merely imagined saying.

In the beginning, not even Hynek Wichterle's postdoc thought his idea to slow the progression of amyotrophic lateral ...

A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.

New advances in brain-computer interface (BCI) technology may make speech for those who've lost the ability to do easier than ...

Long-term exposure to sulfur dioxide, an air pollutant generated by the burning of fossil fuels, increases the risk of ALS, a ...

Tommy and Vickie Smith have faced more than their share of health challenges. Tommy has been living with amyotrophic lateral ...

Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie's Quest, today announced plans to ...